Topical and Systemic Steroids
Özet
Topical and systemic corticosteroids are the mainstays of treatment in various dermatological conditions. However, long-term use should be limited due to the well-known side effects of steroids. Furthermore, in the geriatric population, treatment with these medications requires even more careful consideration in terms of age-related physiological changes, comorbidities, and polypharmacy, all of which may have a significant impact on the efficacy and safety of corticosteroid therapy. This chapter aims to review treatment with steroids focusing on indications, considerations, potential side effects, and management strategies to optimize patient outcomes while minimizing their risks in the elderly population.
Referanslar
Weinstein JR, Anderson S. THE AGING KIDNEY: PHYSIOLOGICAL CHANGES. Adv Chronic Kidney Dis. 2010 Jul;17(4):302–7.
Flammiger A, Maibach H. Drug dosage in the elderly: dermatological drugs. Drugs Aging. 2006;23(3):203–15.
Kaestli LZ, Wasilewski-Rasca AF, Bonnabry P, Vogt-Ferrier N. Use of transdermal drug formulations in the elderly. Drugs Aging. 2008;25(4):269–80.
Jackson S, Gilchrist H, Nesbitt LT. Update on the dermatologic use of systemic glucocorticosteroids. Dermatol Ther. 2007;20(4):187–205.
Courtney R. Schadt, Scott M. Jackson. 125 - Glucocorticoids. In: Bolognia Dermatology. 4th ed. p. 2186–99.
Sidbury R, Alikhan A, Bercovitch L, Cohen DE, Darr JM, Drucker AM, et al. Guidelines of care for the management of atopic dermatitis in adults with topical therapies. J Am Acad Dermatol. 2023 Jul;89(1):e1–20.
Joly P, Horvath B, Patsatsi Α, Uzun S, Bech R, Beissert S, et al. Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the european academy of dermatology and venereology (EADV). J Eur Acad Dermatol Venereol JEADV. 2020 Sep;34(9):1900–13.
Updated S2 K guidelines for the management of bullous pemphigoid initiated by the European Academy of Dermatology and Venereology (EADV) - Borradori - 2022 - Journal of the European Academy of Dermatology and Venereology - Wiley Online Library [Internet]. [cited 2024 Aug 28]. Available from: https://onlinelibrary.wiley.com/doi/10.1111/jdv.18220
Mehta A, Nadkarni N, Patil S, Godse K, Gautam M, Agarwal S. Topical corticosteroids in dermatology. Indian J Dermatol Venereol Leprol. 2016;82(4):371.
Katz M, Gans EH. Topical corticosteroids, structure-activity and the glucocorticoid receptor: discovery and development--a process of “planned serendipity.” J Pharm Sci. 2008 Aug;97(8):2936–47.
Mori M, Pimpinelli N, Giannotti B. Topical corticosteroids and unwanted local effects. Improving the benefit/risk ratio. Drug Saf. 1994 May;10(5):406–12.
McKENZIE AW, STOUGHTON RB. Method for Comparing Percutaneous Absorption of Steroids. Arch Dermatol. 1962 Nov 1;86(5):608–10.
ATCDDD - ATC/DDD Index [Internet]. [cited 2024 Aug 29]. Available from: https://atcddd.fhi.no/atc_ddd_index/?code=D07A&showdescription=no
Joly P, Roujeau JC, Benichou J, Picard C, Dreno B, Delaporte E, et al. A comparison of oral and topical corticosteroids in patients with bullous pemphigoid. N Engl J Med. 2002 Jan 31;346(5):321–7.
Egeberg A, Schwarz P, Harsløf T, Andersen YMF, Pottegård A, Hallas J, et al. Association of Potent and Very Potent Topical Corticosteroids and the Risk of Osteoporosis and Major Osteoporotic Fractures. JAMA Dermatol. 2021 Mar 1;157(3):275.
Iatrogenic Cushing’s syndrome and topical steroid therapy: case series and review of the literature: Journal of Dermatological Treatment: Vol 25 , No 6 - Get Access [Internet]. [cited 2024 Aug 30]. Available from: https://www.tandfonline.com/doi/full/10.3109/09546634.2012.755252
Arya V, Sharma A, Ali M. Iatrogenic Cushing’s syndrome from topical steroid use. Eur J Rheumatol. 2022 Apr;9(2):106.
Sue LY, Milanesi A. Acute Hyperglycemia Due to Topical Corticosteroid Administration. Case Rep Endocrinol. 2019;2019:6058076.
Habif TP. Clinical Dermatology E-Book. Elsevier Health Sciences; 2015. 1089 p.
Joly P, Roujeau JC, Benichou J, Delaporte E, D’Incan M, Dreno B, et al. A comparison of two regimens of topical corticosteroids in the treatment of patients with bullous pemphigoid: a multicenter randomized study. J Invest Dermatol. 2009 Jul;129(7):1681–7.
Lax SJ, Harvey J, Axon E, Howells L, Santer M, Ridd MJ, et al. Strategies for using topical corticosteroids in children and adults with eczema. Cochrane Database Syst Rev. 2022 Mar 11;3(3):CD013356.
Stamou MI, Colling C, Dichtel LE. Adrenal aging and its effects on the stress response and immunosenescence. Maturitas. 2023 Feb;168:13–9.
Allan S. Brett MD. Glucocorticoid-Induced Adrenal Insufficiency: A New Guideline. NEJM J Watch [Internet]. 2024 Jul 18 [cited 2024 Aug 30];2024. Available from: https://www.jwatch.org/NA57722/2024/07/18/glucocorticoid-induced-adrenal-insufficiency-new-guideline
Anstead GM. Steroids, retinoids, and wound healing. Adv Wound Care J Prev Heal. 1998 Oct;11(6):277–85.
Wang AS, Armstrong EJ, Armstrong AW. Corticosteroids and wound healing: clinical considerations in the perioperative period. Am J Surg. 2013 Sep 1;206(3):410–7.
Liu D, Ahmet A, Ward L, Krishnamoorthy P, Mandelcorn ED, Leigh R, et al. A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy. Allergy Asthma Clin Immunol Off J Can Soc Allergy Clin Immunol. 2013 Aug 15;9(1):30.
Moghadam‐Kia S, Werth VP. Prevention and treatment of systemic glucocorticoid side effects. Int J Dermatol. 2010 Mar;49(3):239–48.
The Pathogenesis of Nontraumatic Osteonecrosis - Seamon - 2012 - Arthritis - Wiley Online Library [Internet]. [cited 2024 Aug 31]. Available from: https://onlinelibrary.wiley.com/doi/full/10.1155/2012/601763
Abeles M, Urman JD, Rothfield NF. Aseptic necrosis of bone in systemic lupus erythematosus. Relationship to corticosteroid therapy. Arch Intern Med. 1978 May;138(5):750–4.
Incidence and risk factors for corticosteroid-induced lipodystrophy: A prospective study - ScienceDirect [Internet]. [cited 2024 Sep 2]. Available from: https://www.sciencedirect.com/science/article/abs/pii/S019096220700775X
Severe adverse cardiovascular effects of pulse steroid therapy: Is continuous cardiac monitoring necessary? - ScienceDirect [Internet]. [cited 2024 Sep 2]. Available from: https://www.sciencedirect.com/science/article/abs/pii/S0190962208815083
Saag KG. Short-term and Long-term Safety of Glucocorticoids in Rheumatoid Arthritis. | Bulletin of the NYU Hospital for Joint Diseases | EBSCOhost [Internet]. 2012 [cited 2024 Sep 2]. p. S21. Available from: https://openurl.ebsco.com/contentitem/gcd:83916607?sid=ebsco:plink:crawler&id=ebsco:gcd:83916607
Minden SL, Orav J, Schildkraut JJ. Hypomanic reactions to ACTH and prednisone treatment for multiple sclerosis. Neurology. 1988 Oct;38(10):1631–1631.
Urban RC, Cotlier E. Corticosteroid-induced cataracts. Surv Ophthalmol. 1986 Sep 1;31(2):102–10.
Recommendations of the Advisory Committee on Immunization Practices (ACIP): Use of Vaccines and Immune Globulins in Persons with Altered Immunocompetence [Internet]. [cited 2024 Sep 2]. Available from: https://www.cdc.gov/mmwr/preview/mmwrhtml/00023141.htm
Part 4: Biological Products (Vaccines & Immune Globulins) [Internet]. [cited 2024 Sep 2]. Available from: http://www.bccdc.ca/health-professionals/clinical-resources/communicable-disease-control-manual/immunization/biological-products
British Association of Dermatologists [Internet]. [cited 2024 Sep 4]. Available from: https://www.bad.org.uk/pils/immunisation-advice-for-people-on-immune-suppressing-medicines/
Immunization Manual [Internet]. [cited 2024 Sep 4]. Available from: http://www.bccdc.ca/health-professionals/clinical-resources/communicable-disease-control-manual/immunization
